Cardiac sarcoid remains a challenging diagnostic entity. Electrical abnormalities in sarcoid myocarditis range from heart blocks to lethal ventricular tachycardias. Sarcoid granulomas have predilection for left ventricular side and basal septum in cardiac involvement. We present a case of sarcoid myocarditis presenting as mass involving the entire right ventricular side of the interventricular septum.

Download full-text PDF

Source

Publication Analysis

Top Keywords

sarcoid myocarditis
8
ventricular side
8
cardiac sarcoidosis
4
sarcoidosis masquerading
4
masquerading syncope
4
ventricular
4
syncope ventricular
4
ventricular septal
4
septal mass
4
mass cardiac
4

Similar Publications

Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment.

Diagnostics (Basel)

January 2025

Department of Electrocardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Kraków, Poland.

Cardiac magnetic resonance (CMR) allows for analysis of cardiac function and myocardial tissue characterization. Increased left ventricular mass (LVM) is an independent predictor of cardiovascular events; however, the diagnosis of left ventricular hypertrophy and its prognostic value strongly depend on the LVM indexation method. Evaluation of the quantity and distribution of late gadolinium enhancement assists in clinical decisions on diagnosis, cardiovascular assessment, and interventions, including the placement of cardiac implantable electronic devices and the choice of an optimal procedural approach.

View Article and Find Full Text PDF

Background: Cardiac sarcoidosis (CS) is a chronic inflammatory disease characterised by non-caseating granulomas, while arrhythmogenic cardiomyopathy (ACM) is a genetic condition mainly affecting desmosomal proteins. The coexistence of CS and genetic variants associated with ACM is not well understood, creating challenges in diagnosis and management. This study aimed to describe the clinical, imaging and genetic features of patients with both conditions.

View Article and Find Full Text PDF

Objectives: We present a case series of patients with granulomatous myocarditis presenting as atrial arrhythmias accompanied by lymphadenopathy.

Background: Atrial myocarditis (AM) may be the cause of atrial fibrillation (AF) in patients without risk factors.

Methods: Patients with atrial fibrillation without risk factors underwent 18F-Fluorodeoxyglucose positron emission tomography (18F-FDG-PET).

View Article and Find Full Text PDF

Purpose Of Review: This review aims to explore the clinical significance of atrial fluorodeoxyglucose (FDG) uptake observed in positron emission tomography (PET) scans, focusing on its association with atrial fibrillation (AF), cardiac sarcoidosis, and myocarditis. We discuss the implications of atrial uptake for patient management and prognosis.

Recent Findings: Recent studies have demonstrated that atrial FDG uptake is frequently present in patients with AF, particularly those with persistent AF, and is linked to increased risks of stroke and poorer outcomes after ablation.

View Article and Find Full Text PDF
Article Synopsis
  • Giant cell myocarditis (GCM) and cardiac sarcoidosis have similar symptoms and tissue characteristics, leading to questions about their relationship on the inflammatory cardiomyopathy spectrum.
  • The case involves a patient who experienced cardiogenic shock linked to GCM, confirmed by biopsy.
  • After a heart transplant, the patient was diagnosed with sarcoidosis using 18-fluorodeoxyglucose PET imaging and another biopsy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!